bazedoxifene has been researched along with ridaifen-b in 1 studies
| Studies (bazedoxifene) | Trials (bazedoxifene) | Recent Studies (post-2010) (bazedoxifene) | Studies (ridaifen-b) | Trials (ridaifen-b) | Recent Studies (post-2010) (ridaifen-b) |
|---|---|---|---|---|---|
| 307 | 69 | 249 | 10 | 0 | 8 |
| Protein | Taxonomy | bazedoxifene (IC50) | ridaifen-b (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.0006 | |
| Proteasome subunit beta type-1 | Homo sapiens (human) | 6.37 | |
| Proteasome subunit beta type-5 | Homo sapiens (human) | 6.56 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anantpadma, M; Cheng, H; Cooper, L; Davey, RA; Dye, K; Li, Y; Medegan Fagla, B; Nowar, R; Rong, L; Schafer, A; Shen, Z; Thatcher, GRJ; Xiong, R | 1 |
1 other study(ies) available for bazedoxifene and ridaifen-b
| Article | Year |
|---|---|
Screening and Reverse-Engineering of Estrogen Receptor Ligands as Potent Pan-Filovirus Inhibitors.
Topics: Antiviral Agents; Cell Line, Tumor; Drug Evaluation, Preclinical; Filoviridae; Humans; Ligands; Membrane Fusion; Models, Biological; Receptors, Estrogen; Structure-Activity Relationship | 2020 |